Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00932516 · ClinicalTrials.gov registry record · NA

Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to a Calorie-Restricted Diet in Women

A NA study of Overweight, sponsored by Mondelēz International.

Completed
Registry status
NA
Development phase
248
Enrollment target
4
Study locations

NCT00932516 is a NA study of Overweight that has completed, run by Mondelēz International. The registered enrollment target is 248 participants, below the 1,322-participant average among 197 other Overweight trials with a reported enrollment target (81% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00932516, a NA study of Overweight, has completed, sponsored by Mondelēz International.

COMPLETED
Registry status
NA
Development phase
248 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to examine the effectiveness of the South Beach Diet™ and South Beach Diet™ products compared to a traditional calorie restricted diet.

Conditions Studied

Interventions

  • BEHAVIORAL South Beach Diet™ with South Beach Diet™ Products
  • BEHAVIORAL South Beach Diet™
  • BEHAVIORAL Calorie restricted diet with South Beach Diet™ Products
  • BEHAVIORAL Calorie Restricted Diet

Study Locations (4)

Florida

  • SIBR Research - Bradenton
  • Miami Research Associates - Miami

California

  • Medicus Research - Northridge

Virginia

  • Chase Wellness & Research Center - Virginia Beach

Trial Details

FieldValue
Enrollment Target 248 participants
Start Date 2007-03
Est. Completion 2008-04
Phase NA

Sponsor

Mondelēz International

7 total trials

What the Registry Record Tells You About NCT00932516

The ClinicalTrials.gov registry entry for NCT00932516 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,322-participant average among 197 other Overweight trials with a reported enrollment target (81% lower). The listed sponsor is Mondelēz International, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Overweight appearing as the primary indexed condition, and to 4 interventions - of which South Beach Diet™ with South Beach Diet™ Products is the first listed.

NCT00932516 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Florida, California, Virginia.

Frequently Asked Questions

What is clinical trial NCT00932516 about?

NCT00932516 is a clinical study titled "Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to a Calorie-Restricted Diet in Women". The purpose of this study is to examine the effectiveness of the South Beach Diet™ and South Beach Diet™ products compared to a traditional calorie restricted diet.

What is the current status of trial NCT00932516?

This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2007-03. Estimated completion is 2008-04.

What conditions does trial NCT00932516 study?

This clinical trial studies the following conditions: Overweight.

What interventions are being tested in trial NCT00932516?

The interventions under investigation include: South Beach Diet™ with South Beach Diet™ Products (BEHAVIORAL), South Beach Diet™ (BEHAVIORAL), Calorie restricted diet with South Beach Diet™ Products (BEHAVIORAL), Calorie Restricted Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT00932516?

This trial is sponsored by Mondelēz International, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00932516 being conducted?

This trial has 4 study locations across California, Florida, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.